Aprepitant for severe refractory pruritus in a patient with relapsed Hodgkin lymphoma

被引：0
|
作者：
Al Nassan, Anwar [1 ]
Bazzeh, Faiha [1 ,2 ]
Sultan, Iyad [1 ,2 ,3 ]
机构：
[1] King Hussein Canc Ctr, Dept Pediat, Amman 11194, Jordan
[2] Jordan Univ Hosp, Dept Pediat, Amman, Jordan
[3] King Hussein Canc Ctr, Artificial Intelligence & Data Innovat Off, Amman, Jordan
来源：
PEDIATRIC BLOOD & CANCER | 2024年 / 71卷 / 03期
关键词：
D O I：
10.1002/pbc.30826
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Refractory or relapsed Hodgkin lymphoma
    Connors, J
    ANNALS OF ONCOLOGY, 2005, 16 : 40 - 40
  • [2] Relapsed/refractory Hodgkin lymphoma
    Sheikh, Semira
    Kuruvilla, John
    HEMASPHERE, 2018, 2 : 71 - 74
  • [3] Therapy of relapsed and refractory Hodgkin Lymphoma
    von Tresckow, B.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 62 - 62
  • [4] Managing relapsed and refractory Hodgkin lymphoma
    Brice, Pauline
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 (01) : 3 - 13
  • [5] Pembrolizumab for relapsed or refractory Hodgkin lymphoma
    Pulsoni, Alessandro
    LANCET ONCOLOGY, 2020, 22 (06): : E234 - E234
  • [6] Case Report: Severe COVID-19 Pneumonia in a Patient With Relapsed/Refractory Hodgkin's Lymphoma
    Yonal-Hindilerden, Ipek
    Hindilerden, Fehmi
    Mastanzade, Metban
    Tiryaki, Tarik Onur
    Tasan-Yenigun, Sevim
    Bilen, Yusuf
    Aksoz, Selcuk
    Cagatay, Arif Atahan
    Nalcaci, Meliha
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [7] Relapsed/Refractory Classical Hodgkin Lymphoma
    Winter, Jane N.
    TURKISH JOURNAL OF HEMATOLOGY, 2023, 40 : 34 - 35
  • [8] Treatment of Relapsed/Refractory Hodgkin Lymphoma
    Chen, Robert W.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (02) : 6 - 9
  • [9] Treatment of relapsed and refractory Hodgkin Lymphoma
    von Tresckow, Bastian
    Moskowitz, Craig H.
    SEMINARS IN HEMATOLOGY, 2016, 53 (03) : 180 - 185
  • [10] A Chinese patient with relapsed and refractory Hodgkin lymphoma treated with brentuximab vedotin
    Zhi-Gang Cao
    Hong-Wei Zhou
    Chao-Jin Peng
    Mo Liu
    Yu Du
    Qing-Ming Yang
    Chinese Journal of Cancer, 2013, 32 (09) : 520 - 523
12345